| Novartis Pharma Schweiz AG - Simulect 10 mg, Injektionspräparat | | 54630 | | 02 | | Simulect 10 mg | | Injektionspräparat | | L04AA09 | | Basiliximab | | 27.03.2003 | | |
| | Composition | | Praeparatio cryodesiccata: basiliximabum 10 mg, dinatrii phosphas anhydricus, natrii chloridum, kalii dihydrogenophosphas, saccharum, glycinum, mannitolum, pro vitro, solvens (i.v.): aqua ad iniectabilia 5 ml, corresp. 10 mg, pro 2.5 ml. | | Packungsbestandteile | | Injection preparation | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
